John Parker
John is the Founder and Managing Partner of Springhood Ventures, which invests in life science and healthcare companies transforming the health and care of children. In parallel to this role, he established and manages CH Innovations, the impact-first venture program of the Charles H. Hood Foundation, a Boston-based private foundation that supports pediatric research, where he also serves as a trustee.
John is an observer on the boards of Deck Therapeutics, SmolTap, Nicolette, Argus Cognitive, Anida Pharma, Mesentech, Inc., BioROSA Technologies, and Prapela, Inc.. He also serves on the advisory boards of multiple nonprofit entities, largely around pediatric health and mission-driven healthcare investing, and a number of pre-launch pediatric-focused startups. He is a frequent speaker on pediatric innovation, investment in child health solutions, and mission investing.
Previously, John spent 25 years in the alternative investment industry, including senior roles in venture capital, private equity, and hedge funds. Early in his career he worked in international merchant banking. Although currently living in the Boston area with his wife and their three children, John spent portions of his career in New York, Tokyo, and Sydney and has done business in over 20 countries on 6 continents. John has a BA from Dartmouth College and an MBA from Dartmouth’s Tuck School of Business.